Co-Micardis 80/12.5mg Tablets x28

Co-Micardis 80/12.5mg contains Telmisartan (80mg) and Hydrochlorothiazide (12.5mg). This combination medication effectively lowers blood pressure through dual mechanisms: angiotensin receptor blocking and diuretic action for improved cardiovascular health. Uses Co-Micardis treats hypertension (high blood pressure) in adults when single-agent therapy is insufficient. It’s prescribed for patients requiring combination therapy to achieve target blood pressure goals. The medication helps reduce cardiovascular risks associated with uncontrolled hypertension. Benefits Provides dual mechanism blood pressure control Reduces risk of heart attack and stroke Improves overall cardiovascular health Offers convenient once-daily dosing Reduces fluid retention effectively Protects kidney function in hypertensive patients Well-tolerated with fewer side effects than some alternatives Helps achieve target blood pressure more effectively Reduces need for multiple separate medications How It Works Telmisartan, an ARB, blocks angiotensin II receptors, preventing blood vessel constriction and aldosterone release. Hydrochlorothiazide, a thiazide diuretic, increases sodium and water excretion through the kidneys. Together, they reduce blood volume and relax blood vessels, effectively lowering blood pressure. Dosage Patient Category Starting Dosage Maximum Dosage Adults 1 tablet daily 1 tablet daily Elderly 1 tablet daily 1 tablet daily Take Co-Micardis once daily with or without food, preferably at the same time each day for optimal effectiveness. Duration of Action Co-Micardis begins working within 3-4 hours of administration. Peak blood pressure reduction occurs within 4-8 hours and lasts for 24 hours, providing consistent control throughout the day. Maximum therapeutic effects are typically achieved within 4-8 weeks of regular use. Side Effects Common side effects include dizziness, headache, fatigue, and upper respiratory tract infections. Some patients experience dry cough, muscle cramps, or increased urination. Rare but serious effects include kidney problems, electrolyte imbalances, or severe hypotension requiring medical attention. Warning Co-Micardis may cause severe hypotension, especially with the first dose or after dose increases. Monitor kidney function and electrolyte levels regularly. Can cause fetal harm during pregnancy. Avoid use in patients with severe kidney or liver impairment. May worsen kidney function in some patients. Pregnancy and Breastfeeding Co-Micardis is contraindicated during pregnancy as it can cause fetal harm including kidney damage and death. Discontinue immediately if pregnancy occurs. It’s unknown if the medication passes into breast milk; consult healthcare provider before breastfeeding while taking Co-Micardis. Interaction May increase lithium levels leading to toxicity Enhanced hypotensive effects with other antihypertensive medications NSAIDs may reduce effectiveness and worsen kidney function Possible increased risk of hyperkalemia with potassium supplements May alter blood sugar levels when used with diabetes medications Precaution Monitor blood pressure, kidney function, and electrolyte levels regularly. Use caution in patients with kidney disease, liver impairment, or diabetes. Avoid dehydration and excessive heat exposure. Inform healthcare providers about Co-Micardis use before surgery or medical procedures requiring anesthesia. Important Information Co-Micardis requires regular monitoring of blood pressure and laboratory values. Don’t stop taking suddenly without medical supervision as this may cause dangerous blood pressure increases. Maintain adequate fluid intake unless restricted by your doctor. Store at room temperature away from moisture and heat in original container.